journal article·2025-11Open access

Mechanisms and Pathophysiological Significance of Insulin Resistance in Offspring With Intrauterine Growth Restriction Mediated by Hepatic GR/miR‐1224 Programming

Yongguo Dai, Xiaoling Guo, Pengxia Yu, Dingmei Zhang, Hao Kou, Hui Wang

Advanced Science· Volume 12· Issue 44

Abstract

Abstract Insulin resistance (IR) has fetal origin and gender preference. Here we traced glucose‐insulin phenotypical changes of intrauterine growth restriction (IUGR) female offspring at different ages and explore the mechanism. The IUGR model was established by prenatal caffeine exposure (PCE): dams were orally administered caffeine [(30, 120 mg(kg.d) −1 ] from gestational day 9 to 20. PCE offspring presented decreased basal serum glucose, insulin, and insulin resistance index, accompanied by improved glucose tolerance and insulin sensitivity. However, after postnatal week (PW) 36, all these changes were gradually reversed in age‐dependent manner and finally developed glucose intolerance and IR. Meanwhile, hepatic insulin signaling and glucose uptake were also gone from enhancement to inhibition. Mechanistically, a negative regulation of blood glucocorticoid on hepatic insulin signaling and glucose uptake via glucocorticoid receptor (GR)/miR‐1224 signaling in the PCE offspring was programmed in utero. Postnatally, the persistent decreased blood glucocorticoid and consequent elevated hepatic glucose uptake caused over‐accumulation of advanced glycation end products (AGEs). AGEs promoted inflammation by interacting with its receptor and conversely repressed hepatic insulin signaling and glucose uptake after PW36. Conclusively, PCE‐induced IUGR offspring exhibited a shift from insulin sensitization to IR, which may be related to hepatic insulin signaling changes via GR/miR‐1224 programming.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Birth, Development, and Health · Pancreatic function and diabetes · Diabetes and associated disorders

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmacology School of Basic Medical Sciences Wuhan University Wuhan 430071 China

Department of Pharmacy National Clinical Research Center for Geriatric Disorders Xiangya Hospital of Central South University Changsha 410008 China

Department of Pharmacy Zhongnan Hospital of Wuhan University Wuhan 430071 China

Hubei Provincial Key Laboratory of Developmentally Originated Disease School of Basic Medical Sciences Wuhan University Wuhan 430071 China

Funding

National Basic Research Program of China · National Natural Science Foundation of China

References (100+)

Show source-provided references
1. 10.1055/s-2001-1857610.1055/s-2001-18576 ↗
2. 10.3390/biom1202020810.3390/biom12020208 ↗
3. 10.1016/j.arr.2019.10095710.1016/j.arr.2019.100957 ↗
4. 10.5114/pedm.2019.9154710.5114/pedm.2019.91547 ↗
5. 10.1152/ajpendo.00688.201310.1152/ajpendo.00688.2013 ↗
6. 10.1016/j.bbi.2013.10.02910.1016/j.bbi.2013.10.029 ↗
7. 10.1016/j.eehl.2022.09.00110.1016/j.eehl.2022.09.001 ↗
8. 10.3390/nu1501008710.3390/nu15010087 ↗
9. 10.1007/s00125-018-4694-z10.1007/s00125-018-4694-z ↗
10. Liao Y. · Beijing Da Xue Xue Bao Yi Xue Ban · 2008 · 40 · 590
11. 10.1039/D2FO01481E10.1039/D2FO01481E ↗
12. 10.1210/jc.2005-277810.1210/jc.2005-2778 ↗
13. 10.1002/jcp.2760310.1002/jcp.27603 ↗
14. 10.3390/ijms2216859010.3390/ijms22168590 ↗
15. 10.1016/j.ejphar.2019.17265710.1016/j.ejphar.2019.172657 ↗
16. 10.1155/2018/432171410.1155/2018/4321714 ↗
17. 10.1507/endocrj.EJ12-022810.1507/endocrj.EJ12-0228 ↗
18. 10.1039/D2FO01974D10.1039/D2FO01974D ↗
19. 10.1016/j.ejphar.2009.11.05910.1016/j.ejphar.2009.11.059 ↗
20. 10.1007/s00125005159110.1007/s001250051591 ↗
21. 10.3390/biom1204054210.3390/biom12040542 ↗
22. 10.3390/cells1108131210.3390/cells11081312 ↗
23. 10.1097/HJH.000000000000344910.1097/HJH.0000000000003449 ↗
24. 10.1016/j.tem.2014.07.00310.1016/j.tem.2014.07.003 ↗
25. 10.3390/nu1011177210.3390/nu10111772 ↗
26. 10.2991/efood.k.190802.00110.2991/efood.k.190802.001 ↗
27. 10.1016/j.jfutfo.2023.02.00210.1016/j.jfutfo.2023.02.002 ↗
28. 10.1097/00006842-199807000-0002110.1097/00006842-199807000-00021 ↗
29. 10.1136/bmj.j502410.1136/bmj.j5024 ↗
30. 10.1146/annurev-nutr-071816-06494110.1146/annurev-nutr-071816-064941 ↗
31. 10.1016/j.tem.2019.11.00410.1016/j.tem.2019.11.004 ↗
32. 10.1007/s00394-016-1301-210.1007/s00394-016-1301-2 ↗
33. 10.1080/10408398.2021.194553210.1080/10408398.2021.1945532 ↗
34. 10.3945/ajcn.2009.2879210.3945/ajcn.2009.28792 ↗
35. 10.1136/bmj.a233210.1136/bmj.a2332 ↗
36. 10.1046/j.1365-3016.2003.00507.x10.1046/j.1365-3016.2003.00507.x ↗
37. 10.1111/j.1440-1681.2012.05676.x10.1111/j.1440-1681.2012.05676.x ↗
38. 10.1186/s12916-021-02173-410.1186/s12916-021-02173-4 ↗
39. 10.1016/j.taap.2014.01.00710.1016/j.taap.2014.01.007 ↗
40. 10.26599/FSHW.2025.925071110.26599/FSHW.2025.9250711 ↗
41. 10.1530/JOE-19-006610.1530/JOE-19-0066 ↗
42. 10.1007/s00114-017-1510-410.1007/s00114-017-1510-4 ↗
43. 10.1002/cbin.1032110.1002/cbin.10321 ↗
44. 10.1007/BF0025374410.1007/BF00253744 ↗
45. 10.1097/01.mco.0000172574.64019.9810.1097/01.mco.0000172574.64019.98 ↗
46. 10.1016/j.toxlet.2013.11.00610.1016/j.toxlet.2013.11.006 ↗
47. 10.1016/j.phrs.2019.10455510.1016/j.phrs.2019.104555 ↗
48. 10.1016/j.freeradbiomed.2023.09.02610.1016/j.freeradbiomed.2023.09.026 ↗
49. 10.1016/j.taap.2020.11518710.1016/j.taap.2020.115187 ↗
50. 10.1016/j.scitotenv.2022.15409510.1016/j.scitotenv.2022.154095 ↗
51. 10.1093/toxsci/kfae02710.1093/toxsci/kfae027 ↗
52. 10.1016/j.taap.2020.11497910.1016/j.taap.2020.114979 ↗
53. 10.1371/journal.pone.001522410.1371/journal.pone.0015224 ↗
54. 10.1021/acs.jafc.0c0674810.1021/acs.jafc.0c06748 ↗
55. 10.1016/j.jes.2023.02.02110.1016/j.jes.2023.02.021 ↗
56. 10.26599/FMH.2024.942001610.26599/FMH.2024.9420016 ↗
57. 10.26599/FMH.2024.942000810.26599/FMH.2024.9420008 ↗
58. 10.1002/tox.2363010.1002/tox.23630 ↗
59. 10.1371/journal.pone.004449710.1371/journal.pone.0044497 ↗
60. 10.3389/fgene.2019.0127010.3389/fgene.2019.01270 ↗
61. 10.1017/S204017441800038710.1017/S2040174418000387 ↗
62. 10.3390/biom501019410.3390/biom5010194 ↗
63. 10.1016/j.jnutbio.2019.05.01610.1016/j.jnutbio.2019.05.016 ↗
64. 10.1590/S0102-311X200700120000210.1590/S0102-311X2007001200002 ↗
65. 10.1093/ajcn/nqy21910.1093/ajcn/nqy219 ↗
66. 10.1186/s12916-014-0174-610.1186/s12916-014-0174-6 ↗
67. 10.1093/jas/sky45710.1093/jas/sky457 ↗
68. 10.1371/journal.pone.002516710.1371/journal.pone.0025167 ↗
69. 10.31744/einstein_journal/2022AO677810.31744/einstein_journal/2022AO6778 ↗
70. 10.1002/ajhb.2059010.1002/ajhb.20590 ↗
71. 10.1111/eci.1362510.1111/eci.13625 ↗
72. 10.1016/j.eehl.2024.04.00810.1016/j.eehl.2024.04.008 ↗
73. 10.1111/j.1365-2826.2008.01663.x10.1111/j.1365-2826.2008.01663.x ↗
74. Sedaghat K. · Iran J Basic Med Sci · 2015 · 18 · 212
75. 10.1039/C5TX00265F10.1039/C5TX00265F ↗
76. 10.1016/j.taap.2012.08.01610.1016/j.taap.2012.08.016 ↗
77. Wang H. · Chin J Pharmacol Toxicol · 2017 · 31 · 12
78. 10.1016/j.fct.2022.11308210.1016/j.fct.2022.113082 ↗
79. 10.1016/j.scitotenv.2021.14769110.1016/j.scitotenv.2021.147691 ↗
80. 10.1016/j.tox.2019.02.00810.1016/j.tox.2019.02.008 ↗
81. 10.1016/j.tox.2014.08.01510.1016/j.tox.2014.08.015 ↗
82. 10.1016/j.tox.2019.15230810.1016/j.tox.2019.152308 ↗
83. 10.1177/1753495X1984783210.1177/1753495X19847832 ↗
84. 10.3389/fimmu.2019.0154510.3389/fimmu.2019.01545 ↗
85. 10.1113/EP08521210.1113/EP085212 ↗
86. 10.3892/ijmm.2016.249910.3892/ijmm.2016.2499 ↗
87. Zhang Q. · Int. J. Mol. Med. · 2018 · 41 · 1547
88. 10.1007/s11010-022-04587-x10.1007/s11010-022-04587-x ↗
89. 10.1016/bs.vh.2024.02.00710.1016/bs.vh.2024.02.007 ↗
90. 10.1007/s00018-020-03566-z10.1007/s00018-020-03566-z ↗
91. 10.1530/JOE-18-068410.1530/JOE-18-0684 ↗
92. 10.1016/j.reprotox.2017.06.04510.1016/j.reprotox.2017.06.045 ↗
93. 10.1038/srep3410610.1038/srep34106 ↗
94. 10.1016/j.taap.2013.11.02010.1016/j.taap.2013.11.020 ↗
95. 10.1016/j.scitotenv.2021.14844010.1016/j.scitotenv.2021.148440 ↗
96. 10.1016/j.tox.2020.15253310.1016/j.tox.2020.152533 ↗
97. WHO Guidelines Approved by the Guidelines Review Committee · 2016
98. Efsa Panel on Dietetic Products N · EFSA J. · 2015 · 13 · 4102
99. 10.1016/j.molmed.2017.05.00210.1016/j.molmed.2017.05.002 ↗
100. 10.1096/fj.201701557R10.1096/fj.201701557R ↗